key: cord-0856806-16vt8wq4 authors: Mohkhedkar, Mugdha; Venigalla, Siva Sai Krishna; Janakiraman, Vani title: Possible auto-antigens that may explain the post-infection autoimmune manifestations in COVID-19 patients displaying neurological conditions date: 2020-11-07 journal: J Infect Dis DOI: 10.1093/infdis/jiaa703 sha: bcc494794da06bfca5a5815933426797ee6c55cf doc_id: 856806 cord_uid: 16vt8wq4 nan M a n u s c r i p t 2 To the editor-We read with interest the article 'Immunoserologic detection and diagnostic relevance of cross-reactive autoantibodies in Coronavirus disease 2019 patients' by Schiaffino et al., [1] . They reported a unique immunofluorescence (IF) pattern on rat tissues for 12 hospitalized COVID-19 patients' sera. The observed COVID-19 specific IF pattern (COVID-IF) suggested the presence of non-organ specific autoreactive antibodies in affected patients. Furthermore, the COVID-IF patients displayed neurological and thrombotic conditions with a strong temporal association with COVID-19. Of the three patients with neurological conditions, one with Guillain-Barre syndrome (GBS) was also found to possess autoantibodies in cerebrospinal fluid (CSF-positive for COVID-IF). Evidence presented for seroconversion from negative to positive in a patient's pre-and post-COVID-19 serum samples respectively, suggested a causal relationship between generation of autoreactive antibodies and COVID-19. The authors postulatedmolecular mimicry as a possible mechanism for the observed neurological and thrombotic manifestations [1] . Here, we report 4 human proteins involved in autoimmunity that potentially act as autoantigens in COVID-19 patients with neurological damage. We screened for shared B cell epitopes between humans and SARS-CoV-2. To collect B cell epitopes on SARS-CoV-2, a search was performed on PubMed using the keywords "immunogenic regions SARS-CoV-2" and "B-cell epitopes SARS-CoV-2". B cell immunogenic epitopes (from papers published before 8 Aug 2020) reported through various computational prediction methods and/or experimental verification methods were compiled to create a library. For further analysis, it was ensured that the epitopes selected from the library were experimentally identified/validated. BLASTp program A c c e p t e d M a n u s c r i p t 3 (https://blast.ncbi.nlm.nih.gov/Blast.cgi) [2] was used to search for human encoded proteins that shared homologous sequences with the immunogenic peptides. The search set was limited to Homo sapiens in the UniProtKB/Swiss-Prot database. Default BLASTp algorithm parameters were used and the results were limited only to the top 100 hits.The protein list obtained from the BLAST search was manually curated using the Open Targets Platform [3] server to identify if a given protein had been previously reported to have autoantibodies generated against it in autoimmune conditions. Our results include 4 human proteins homologous to SARS-COV-2 that could possibly be acting as autoantigens in COVID-19 patients displaying neurological conditions. One of them is Heat Shock Protein 90 alpha family class B member 1 (HSP90AB1, known to be involved in GBS [4] ), as previously reported [5] . The other three are heat shock protein family A (Hsp70) member 5 (HSPA5/GRP78, involved in neuromyelitis optica [6] ), titin (TTN, involved in myasthenia gravis [7] ) and ryanodine receptor 2 (RYR2, involved in myasthenia gravis [8] ). Epitope sequences on SARS-CoV-2 and homologous human selfantigen sequences are as given in the table. Cases reported by Schiaffino et al., [1] A c c e p t e d M a n u s c r i p t 5 Authors declare that there are no competing interests. There was no particular funding support for this work. Immunoserologic Detection and Diagnostic Relevance of Cross-Reactive Autoantibodies in Coronavirus Disease Basic local alignment search tool Open Targets Platform: New developments and updates two years on Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain-Barré syndrome SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica Anti-titin antibodies in myasthenia gravis: Tight association with thymoma and heterogeneity of nonthymoma patients Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients A subcellular map of the human proteome A c c e p t e d M a n u s c r i p t 6 A c c e p t e d M a n u s c r i p t 7 autoantibodies in myasthenia gravis patients with a thymoma. Ann Neurol. 1992;